Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Biological Unit 1
(-)Biological Unit 2
(-)Biological Unit 3
(-)Biological Unit 4
(-)Biological Unit 5
(-)Biological Unit 6
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)
Image Biological Unit 4
Biological Unit 4  (Jmol Viewer)
Image Biological Unit 5
Biological Unit 5  (Jmol Viewer)
Image Biological Unit 6
Biological Unit 6  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF THE PTPN4 PDZ DOMAIN COMPLEXED WITH THE C-TERMINUS OF THE GLUN2A NMDA RECEPTOR SUBUNIT
 
Authors :  N. Babault, F. Cordier, M. Lafage, J. Cockburn, A. Haouz, F. A. Rey, M. De H. Buc, M. Lafon, N. Wolff
Date :  10 Jun 10  (Deposition) - 24 Aug 11  (Release) - 30 Nov 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.91
Chains :  Asym. Unit :  A,B,C,D,E,F,G,H
Biol. Unit 1:  A,E  (1x)
Biol. Unit 2:  B,F  (1x)
Biol. Unit 3:  C,G  (1x)
Biol. Unit 4:  D,H  (1x)
Biol. Unit 5:  A (1x),D (1x),E (1x),H (1x)
Biol. Unit 6:  B (1x),C (1x),F (1x),G (1x)
Keywords :  Pdz-Pdz-Binding Site Complex, Protein Binding (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  N. Babault, F. Cordier, M. Lafage, J. Cockburn, A. Haouz, C. Prehaud, F. A. Rey, M. Delepierre, H. Buc, M. Lafon, N. Wolff
Peptides Targeting The Pdz Domain Of Ptpn4 Are Efficient Inducers Of Glioblastoma Cell Death.
Structure V. 19 1518 2011
PubMed-ID: 22000519  |  Reference-DOI: 10.1016/J.STR.2011.07.007

(-) Compounds

Molecule 1 - TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 4
    ChainsA, B, C, D
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPDEST15
    Expression System StrainBL21 (DE3) STAR
    Expression System Taxid469008
    Expression System Vector TypePLASMID
    FragmentPDZ DOMAIN (UNP RESIDUES 499-604)
    GenePTPN4
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymPROTEIN-TYROSINE PHOSPHATASE MEG1, PTPASE-MEG1, MEG
 
Molecule 2 - GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1
    ChainsE, F, G, H
    EngineeredYES
    FragmentUNP RESIDUES 1449-1464
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsNR2A16 PEPTIDE HAS BEEN CHEMICALLY SYNTHETIZED. THE SEQUENCE OCUURS NATURALLY IN HOMO SAPIENS (HUMAN)
    SynonymN-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A, NMDAR2A, NR2A, HNR2A
    SyntheticYES

 Structural Features

(-) Chains, Units

  12345678
Asymmetric Unit ABCDEFGH
Biological Unit 1 (1x)A   E   
Biological Unit 2 (1x) B   F  
Biological Unit 3 (1x)  C   G 
Biological Unit 4 (1x)   D   H
Biological Unit 5 (1x)A (1x)  D (1x)E (1x)  H (1x)
Biological Unit 6 (1x) B (1x)C (1x)  F (1x)G (1x) 

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (0, 0)

(no "Ligand,Modified Residues,Ions" information available for 3NFL)

(-) Sites  (0, 0)

(no "Site" information available for 3NFL)

(-) SS Bonds  (2, 2)

Asymmetric Unit
No.Residues
1A:590 -D:590
2B:590 -C:590

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1Val A:557 -Pro A:558
2Val B:557 -Pro B:558
3Val C:557 -Pro C:558
4Val D:557 -Pro D:558

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 4)

Asymmetric Unit (1, 4)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---E/F/G/HS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---ES14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---FS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 3 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---GS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 4 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---HS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 5 (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---E/HS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 6 (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_067753S1462CNMDE1_HUMANUnclassified  ---F/GS14C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 4)

Asymmetric Unit (1, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  4A:517-589
B:517-589
C:517-589
D:517-589
Biological Unit 1 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  1A:517-589
-
-
-
Biological Unit 2 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  1-
B:517-589
-
-
Biological Unit 3 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  1-
-
C:517-589
-
Biological Unit 4 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  1-
-
-
D:517-589
Biological Unit 5 (1, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  2A:517-589
-
-
D:517-589
Biological Unit 6 (1, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDZPS50106 PDZ domain profile.PTN4_HUMAN517-589
 
 
 
  2-
B:517-589
C:517-589
-

(-) Exons   (3, 12)

Asymmetric Unit (3, 12)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002637081aENSE00001202414chr2:120517207-120517960754PTN4_HUMAN-00--
1.4bENST000002637084bENSE00002161456chr2:120567413-120567567155PTN4_HUMAN1-46460--
1.5bENST000002637085bENSE00001071386chr2:120620112-120620219108PTN4_HUMAN47-82360--
1.6ENST000002637086ENSE00001071393chr2:120634899-12063494143PTN4_HUMAN83-97150--
1.7bENST000002637087bENSE00001071383chr2:120635040-12063511879PTN4_HUMAN97-123270--
1.9bENST000002637089bENSE00001071380chr2:120639362-12063940645PTN4_HUMAN123-138160--
1.10aENST0000026370810aENSE00001071395chr2:120639673-12063972553PTN4_HUMAN138-156190--
1.11bENST0000026370811bENSE00001071376chr2:120640079-120640199121PTN4_HUMAN156-196410--
1.12ENST0000026370812ENSE00001071384chr2:120643371-12064345888PTN4_HUMAN196-225300--
1.13ENST0000026370813ENSE00001730738chr2:120658294-12065838289PTN4_HUMAN226-255300--
1.14aENST0000026370814aENSE00001694309chr2:120672755-12067281864PTN4_HUMAN255-276220--
1.15ENST0000026370815ENSE00001803769chr2:120677645-120677817173PTN4_HUMAN277-334580--
1.16ENST0000026370816ENSE00001640493chr2:120684174-12068424269PTN4_HUMAN334-357240--
1.17bENST0000026370817bENSE00001645678chr2:120690000-120690125126PTN4_HUMAN357-399430--
1.18aENST0000026370818aENSE00001696851chr2:120692376-120692534159PTN4_HUMAN399-452540--
1.19ENST0000026370819ENSE00001749019chr2:120702657-120702816160PTN4_HUMAN452-505540--
1.20ENST0000026370820ENSE00001771605chr2:120703917-12070400084PTN4_HUMAN506-533284A:512-533
B:512-533
C:511-533
D:513-533
22
22
23
21
1.21aENST0000026370821aENSE00001594878chr2:120704094-12070415057PTN4_HUMAN534-552194A:534-552
B:534-552
C:534-552
D:534-552
19
19
19
19
1.22ENST0000026370822ENSE00001621051chr2:120709549-120709705157PTN4_HUMAN553-605534A:553-603
B:553-603 (gaps)
C:553-604 (gaps)
D:553-604 (gaps)
51
51
52
52
1.23ENST0000026370823ENSE00001731922chr2:120712733-120712899167PTN4_HUMAN605-660560--
1.24ENST0000026370824ENSE00001660931chr2:120714420-12071451091PTN4_HUMAN661-691310--
1.25ENST0000026370825ENSE00001797325chr2:120714592-12071465362PTN4_HUMAN691-711210--
1.26bENST0000026370826bENSE00001751186chr2:120718383-120718529147PTN4_HUMAN712-760490--
1.27ENST0000026370827ENSE00001765275chr2:120720192-120720320129PTN4_HUMAN761-803430--
1.28ENST0000026370828ENSE00001760145chr2:120723073-120723221149PTN4_HUMAN804-853500--
1.29bENST0000026370829bENSE00001771727chr2:120725413-120725548136PTN4_HUMAN853-898460--
1.30cENST0000026370830cENSE00001703057chr2:120734560-1207413946835PTN4_HUMAN899-926280--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:92
 aligned with PTN4_HUMAN | P29074 from UniProtKB/Swiss-Prot  Length:926

    Alignment length:92
                                   521       531       541       551       561       571       581       591       601  
          PTN4_HUMAN    512 HDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRP  603
               SCOP domains d3nfla_ A: Tyrosine-protein phosphatase non-receptor type 4, PTPN4                           SCOP domains
               CATH domains -------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeee.........eeeeeehhhheeeeeeee...hhhhhh........eeeee..ee....hhhhhhhhhhhhhhhhhhheeeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -----PDZ  PDB: A:517-589 UniProt: 517-589                                     -------------- PROSITE
               Transcript 1 Exon 1.20 [INCOMPLETE]Exon 1.21a         Exon 1.22  PDB: A:553-603 UniProt: 553-605          Transcript 1
                3nfl A  512 HDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRP  603
                                   521       531       541       551       561       571       581       591       601  

Chain B from PDB  Type:PROTEIN  Length:89
 aligned with PTN4_HUMAN | P29074 from UniProtKB/Swiss-Prot  Length:926

    Alignment length:92
                                   521       531       541       551       561       571       581       591       601  
          PTN4_HUMAN    512 HDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRP  603
               SCOP domains d3nflb_ B: Tyrosine-protein phosphatase non-receptor type 4, PTPN4                           SCOP domains
               CATH domains -------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeee.........eeeeee....eeeeeeee...hhhhhh........eeeee..ee....hhhhhhhhhhh..---...eeeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -----PDZ  PDB: B:517-589 UniProt: 517-589                                     -------------- PROSITE
               Transcript 1 Exon 1.20 [INCOMPLETE]Exon 1.21a         Exon 1.22  PDB: B:553-603 (gaps) UniProt: 553-605   Transcript 1
                3nfl B  512 HDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASC---SGELMLLVRP  603
                                   521       531       541       551       561       571       581        |-  |    601  
                                                                                                        590 594         

Chain C from PDB  Type:PROTEIN  Length:89
 aligned with PTN4_HUMAN | P29074 from UniProtKB/Swiss-Prot  Length:926

    Alignment length:94
                                   520       530       540       550       560       570       580       590       600    
          PTN4_HUMAN    511 PHDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPN  604
               SCOP domains d3nflc_ C: Tyrosine-protein phosphatase non-receptor type 4, PTPN4                             SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeee.........eeeeeehhhheeeeeeee...hhhhhh........eeeee..ee....hhhhhhhhhhh..-----.eeeeee.. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ------PDZ  PDB: C:517-589 UniProt: 517-589                                     --------------- PROSITE
               Transcript 1 Exon 1.20 [INCOMPLETE] Exon 1.21a         Exon 1.22  PDB: C:553-604 (gaps) UniProt: 553-605    Transcript 1
                3nfl C  511 PHDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASC-----ELMLLVRPN  604
                                   520       530       540       550       560       570       580       590     | 600    
                                                                                                         590   596        

Chain D from PDB  Type:PROTEIN  Length:89
 aligned with PTN4_HUMAN | P29074 from UniProtKB/Swiss-Prot  Length:926

    Alignment length:92
                                   522       532       542       552       562       572       582       592       602  
          PTN4_HUMAN    513 DNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPN  604
               SCOP domains d3nfld_ D: Tyrosine-protein phosphatase non-receptor type 4, PTPN4                           SCOP domains
               CATH domains -------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...eeeee.........eeeeeehhhheeeeeeee...hhhhhh........eeeee..ee....hhhhhhhhhh....---..eeeeee.. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ----PDZ  PDB: D:517-589 UniProt: 517-589                                     --------------- PROSITE
               Transcript 1 Exon 1.20            Exon 1.21a         Exon 1.22  PDB: D:553-604 (gaps) UniProt: 553-605    Transcript 1
                3nfl D  513 DNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCE---GELMLLVRPN  604
                                   522       532       542       552       562       572       582        |-  |    602  
                                                                                                        591 595         

Chain E from PDB  Type:PROTEIN  Length:5
 aligned with NMDE1_HUMAN | Q12879 from UniProtKB/Swiss-Prot  Length:1464

    Alignment length:5
         NMDE1_HUMAN   1460 IESDV 1464
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author .eeee Sec.struct. author
                 SAPs(SNPs) --C-- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                3nfl E   12 IESDV   16

Chain F from PDB  Type:PROTEIN  Length:5
 aligned with NMDE1_HUMAN | Q12879 from UniProtKB/Swiss-Prot  Length:1464

    Alignment length:5
         NMDE1_HUMAN   1460 IESDV 1464
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author .eee. Sec.struct. author
                 SAPs(SNPs) --C-- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                3nfl F   12 IESDV   16

Chain G from PDB  Type:PROTEIN  Length:5
 aligned with NMDE1_HUMAN | Q12879 from UniProtKB/Swiss-Prot  Length:1464

    Alignment length:5
         NMDE1_HUMAN   1460 IESDV 1464
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author .eeee Sec.struct. author
                 SAPs(SNPs) --C-- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                3nfl G   12 IESDV   16

Chain H from PDB  Type:PROTEIN  Length:5
 aligned with NMDE1_HUMAN | Q12879 from UniProtKB/Swiss-Prot  Length:1464

    Alignment length:5
         NMDE1_HUMAN   1460 IESDV 1464
               SCOP domains ----- SCOP domains
               CATH domains ----- CATH domains
               Pfam domains ----- Pfam domains
         Sec.struct. author .eee. Sec.struct. author
                 SAPs(SNPs) --C-- SAPs(SNPs)
                    PROSITE ----- PROSITE
                 Transcript ----- Transcript
                3nfl H   12 IESDV   16

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 4)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3NFL)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 3NFL)

(-) Gene Ontology  (74, 77)

Asymmetric Unit(hide GO term definitions)
Chain A,B,C,D   (PTN4_HUMAN | P29074)
molecular function
    GO:0008092    cytoskeletal protein binding    Interacting selectively and non-covalently with any protein component of any cytoskeleton (actin, microtubule, or intermediate filament cytoskeleton).
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0004726    non-membrane spanning protein tyrosine phosphatase activity    Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate.
    GO:0016791    phosphatase activity    Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
    GO:0004721    phosphoprotein phosphatase activity    Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004725    protein tyrosine phosphatase activity    Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
biological process
    GO:0016311    dephosphorylation    The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
    GO:0035335    peptidyl-tyrosine dephosphorylation    The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
    GO:0006470    protein dephosphorylation    The process of removing one or more phosphoric residues from a protein.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009898    cytoplasmic side of plasma membrane    The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0005856    cytoskeleton    Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain E,F,G,H   (NMDE1_HUMAN | Q12879)
molecular function
    GO:0004972    NMDA glutamate receptor activity    An cation channel that opens in response to binding by extracellular glutmate, but only if glycine is also bound and the membrane is depolarized. Voltage gating is indirect, due to ejection of bound magnesium from the pore at permissive voltages.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0005262    calcium channel activity    Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
    GO:0005261    cation channel activity    Enables the energy-independent passage of cations across a lipid bilayer down a concentration gradient.
    GO:0005234    extracellular-glutamate-gated ion channel activity    Enables the transmembrane transfer of an ion by a channel that opens when extracellular glutamate has been bound by the channel complex or one of its constituent parts.
    GO:0005216    ion channel activity    Enables the facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. May be either selective (it enables passage of a specific ion only) or non-selective (it enables passage of two or more ions of same charge but different size).
    GO:0004970    ionotropic glutamate receptor activity    Catalysis of the transmembrane transfer of an ion by a channel that opens when glutamate has been bound by the channel complex or one of its constituent parts.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004872    receptor activity    Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0070588    calcium ion transmembrane transport    A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
    GO:0006816    calcium ion transport    The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0098655    cation transmembrane transport    A process in which a cation is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
    GO:0007268    chemical synaptic transmission    The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
    GO:0033058    directional locomotion    Self-propelled movement of a cell or organism from one location to another along an axis.
    GO:0042417    dopamine metabolic process    The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
    GO:0060079    excitatory postsynaptic potential    A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
    GO:0007215    glutamate receptor signaling pathway    A series of molecular signals initiated by the binding of glutamate to a glutamate receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0006811    ion transport    The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0035235    ionotropic glutamate receptor signaling pathway    A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, followed by the movement of ions through a channel in the receptor complex. Ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0007612    learning    Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
    GO:0007611    learning or memory    The acquisition and processing of information and/or the storage and retrieval of this information over time.
    GO:0040011    locomotion    Self-propelled movement of a cell or organism from one location to another.
    GO:0060291    long-term synaptic potentiation    A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse.
    GO:0007613    memory    The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
    GO:0050804    modulation of chemical synaptic transmission    Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
    GO:0042177    negative regulation of protein catabolic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
    GO:0022008    neurogenesis    Generation of cells within the nervous system.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043065    positive regulation of apoptotic process    Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
    GO:1900273    positive regulation of long-term synaptic potentiation    Any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation.
    GO:0008104    protein localization    Any process in which a protein is transported to, or maintained in, a specific location.
    GO:0042391    regulation of membrane potential    Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
    GO:0060078    regulation of postsynaptic membrane potential    Any process that modulates the potential difference across a post-synaptic membrane.
    GO:0051930    regulation of sensory perception of pain    Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
    GO:0048167    regulation of synaptic plasticity    A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
    GO:0001975    response to amphetamine    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0045471    response to ethanol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
    GO:0009611    response to wounding    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
    GO:0019233    sensory perception of pain    The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process.
    GO:0042428    serotonin metabolic process    The chemical reactions and pathways involving serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.
    GO:0030431    sleep    Any process in which an organism enters and maintains a periodic, readily reversible state of reduced awareness and metabolic activity. Usually accompanied by physical relaxation, the onset of sleep in humans and other mammals is marked by a change in the electrical activity of the brain.
    GO:0001964    startle response    An action or movement due to the application of a sudden unexpected stimulus.
    GO:0006810    transport    The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
    GO:0008542    visual learning    Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.
cellular component
    GO:0017146    NMDA selective glutamate receptor complex    An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. NMDA receptors are composed of assemblies of NR1 subunits (Figure 3) and NR2 subunits, which can be one of four separate gene products (NR2A-D). Expression of both subunits are required to form functional channels. The glutamate binding domain is formed at the junction of NR1 and NR2 subunits. NMDA receptors are permeable to calcium ions as well as being permeable to other ions. Thus NMDA receptor activation leads to a calcium influx into the post-synaptic cells, a signal thought to be crucial for the induction of NMDA-receptor dependent LTP and LTD.
    GO:0030054    cell junction    A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0043005    neuron projection    A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0014069    postsynaptic density of dendrite    An electron dense network of proteins within and adjacent to the postsynaptic membrane of the dendrite of asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
    GO:0045211    postsynaptic membrane    A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.
    GO:0042734    presynaptic membrane    A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
    GO:0045202    synapse    The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
    GO:0008021    synaptic vesicle    A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 3nfl)
 
  Sites
(no "Sites" information available for 3nfl)
 
  Cis Peptide Bonds
    Val A:557 - Pro A:558   [ RasMol ]  
    Val B:557 - Pro B:558   [ RasMol ]  
    Val C:557 - Pro C:558   [ RasMol ]  
    Val D:557 - Pro D:558   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]
    Biological Unit 4  [ Jena3D ]
    Biological Unit 5  [ Jena3D ]
    Biological Unit 6  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3nfl
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  NMDE1_HUMAN | Q12879
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  PTN4_HUMAN | P29074
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  NMDE1_HUMAN | Q12879
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  PTN4_HUMAN | P29074
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        NMDE1_HUMAN | Q128795h8f 5h8h 5h8n 5h8q 5i2k 5i2n 5kcj 5kdt 5tp9 5tpa
        PTN4_HUMAN | P290742cs5 2i75 2vph 3nfk 5eyz 5ez0

(-) Related Entries Specified in the PDB File

2cs5 SOLUTION STRUCTURE OF PTPN4-PDZ
2vph CRYSTAL STRUCTURE OF PTPN4-PDZ
3nfk